Effects of Ezetimibe on Postprandial Hyperlipidemia and Endothelial Function
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
In the present study the investigators are researching the effects of the cholesterol
absorption inhibitor ezetimibe on postprandial lipemia and postprandial endothelial function
in patients with the metabolic syndrome. The lipid-lowering effect of high-dose statin
monotherapy on fasting lipids is equal to the combination therapy of low-dose statin and
ezetimibe.
Phase:
Phase 4
Details
Lead Sponsor:
UMC Utrecht
Treatments:
Ezetimibe Ezetimibe, Simvastatin Drug Combination Simvastatin